NCT01706458View on ClinicalTrials.gov

Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 20, 2013

Primary Completion Date

June 12, 2017

Study Completion Date

August 13, 2020

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

sipuleucel-T

Given IV

BIOLOGICAL

DNA Vaccine

Given ID

Trial Locations (1)

53792

University of Wisconsin Carbone Cancer Center, Madison

Sponsors

Collaborators (1)

Dendreon
All Listed Sponsors
collaborator

Dendreon

INDUSTRY

lead

University of Wisconsin, Madison

OTHER